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In a developing organism, tissues emerge from coordinated sequences of cell renewal, differentiation, and as-
sembly that are orchestrated by spatial and temporal gradients of multiple regulatory factors. The composition,
architecture, signaling, and biomechanics of the cellular microenvironment act in concert to provide the necessary
cues regulating cell function in the developing and adult organism. With recent major advances in stem cell
biology, tissue engineering is becoming increasingly oriented toward biologically inspired in vitro cellular mi-
croenvironments designed to guide stem cell growth, differentiation, and functional assembly. The premise is that
to unlock the full potential of stem cells, at least some aspects of the dynamic three-dimensional (3D) environments
that are associated with their renewal, differentiation, and assembly in native tissues need to be reconstructed.
In the general context of tissue engineering, we discuss the environments for guiding stem cell function by an
interactive use of biomaterial scaffolds and bioreactors, and focus on the interplay betweenmolecular and physical
regulatory factors. We highlight some illustrative examples of controllable cell environments developed through
the interaction of stem cell biology and tissue engineering at multiple levels.
Introduction
Ahundred years ago, in 1907 at Johns Hopkins Uni-versity, Ross Harrison conducted his landmark experi-
ment that involved the cultivation of an embryonic tissue. He
dissected neural tube fragments from tiny frog embryos and
established an in vitro culture to study the outgrowth of nerve
fibers.1 These experiments formed the foundation of modern
nerve physiology and neurology andmarked the beginning of
animal cell and tissue cultures. Harrison also pioneered the
techniques of organ transplantation. Many others followed
his work, making further breakthroughs and developing the
methods we now use to study stem cells and to engineer tis-
sues. The ‘‘tool box’’ currently being developed by tissue en-
gineers may again change the way we conduct cell and tissue
culture experiments, by favoring controllable tissue models of
high fidelity over two-dimensional (2D) Petri dishes. Stan-
dard protocols for the expansion of stem cells still involve
cultivation in 2D settings (e.g., on tissue culture plastics or
feeder layers), whereas cell differentiation commonly requires
transfer into a three-dimensional (3D) setting (e.g., pellet
culture and embryoid bodies). This ‘‘batch’’ culture (i.e., pe-
riodic exchange of medium) and limited application of regu-
latory signals (a bolus) seriously impair our ability to fully
explore the self-renewal and differentiation of stem cells and
their potential to form functional tissues. Recent studies of
cancer cells in 3D cell culture models underscore the impor-
tance of cell interactions within a 3D context and suggest that
the use of 3D models can provide a much needed bridge be-
tween cancer studies in cells and in whole organisms.2
The field of tissue engineering is driven by the need to
provide functional equivalents of native tissues that can be
used for implantation. With the aging population and in-
creasing expectations for a high quality of life, the need
continues to grow, and the field of tissue engineering is re-
sponding to it relatively slowly, due to issues such as the
immense biological complexity, complex regulatory issues,
and the high cost of new cell-based devices. At the same
time, engineered tissues are finding new roles as models for
fundamental research, studies of disease, testing of drugs,
and many other applications. In all cases, the requirements
are to provide the cells with the appropriate cues, to control
the conditions in the cell microenvironment, and to monitor
cellular responses on multiple hierarchical levels. In a devel-
oping organism, tissues emerge from coordinated sequences
of cell renewal, differentiation, and assembly, within an ever-
changing environment characterized by spatial and temporal
gradients of multiple factors. To direct cells to differentiate
at the right time, in the right place, and into the right phe-
notype, one needs to recreate the right environment, with
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biology and engineering interacting at multiple levels. One
approach is to characterize the native tissue environments so
that specific cues may be identified in vivo and then provided
in vitro as controllable parameters that can be experimentally
optimized for synergistic interactions within the cellular
microenvironment.
We follow here a paradigm that a living cell is the only
‘‘tissue engineer,’’ and that by engineering the culture envi-
ronment we can guide cell differentiation and functional as-
sembly. In the general context of technologies for tissue
engineering, we discuss the environments for guiding stem
cell function,with a particular focus on two key components—
biomaterial scaffolds and bioreactors. For both components,
we focus on the interplay between molecular and physical
regulatory factors and highlight some of the important find-
ings toward the design of cell–scaffold–bioreactor systems for
applications in tissue engineering and biological and medical
research.
Biomimetic Approach
In a living organism, cells are surrounded by other cells and
embedded in an extracellular matrix (ECM) that defines
the architecture, signaling, and biomechanics of the cellular
microenvironment. The supply of nutrients and removal of
metabolites are provided by capillary networks, the density of
which is dependent on the metabolic needs of the cells. Cel-
lular processes are mediated by a variety of molecular,
structural, hydrodynamic, mechanical, and electrical cues and
their spatial and temporal levels and combinations. Cells re-
spond to and remodel their immediatemicroenvironment, via
homotypic or heterotypic interactions with neighboring cells,
and with the tissue matrix. It is obvious that the biological
complexity of the native cell context is not mimicked in the
laboratory under standard 2D culture conditions. This is a
major limitation to experiments investigating cellular re-
sponses in vitro since much of the complex interplay of me-
chanical and molecular factors present in vivo is absent.3
Interestingly, the first two communities to realize the signifi-
cance of these differences were cancer biologists4 and tissue
engineers,5,6 and then followed more recently by stem cell
researchers.7,8
It has been argued that we need a new generation of 3D
culture systems that would be ‘‘something between a Petri
dish and a mouse,’’ to authentically represent a cell’s envi-
ronment in a living organism and be more predictive of
in vivo systems.9 For stem cells in particular, to unlock their
full potential and obtain biologically sound and relevant data
in vitro, at least some aspects of the dynamic 3D environ-
ments that are associated with their renewal, differentiation,
and assembly into tissues need to be reconstructed. A fun-
damental approach to the in vitro formation of engineered
tissues is to direct the 3D organization of cells (via bioma-
terial scaffolds) and to establish the conditions necessary for
the cells to reconstruct a functional tissue structure (via
bioreactors). This approach is based on a premise that cells’
responses to environmental factors are predictable, and that
the cell function in vitro can be modulated by the same
complex factors known to play a role during development
and remodeling.
Biomaterial scaffolds provide structural templates for cell
attachment and tissue growth, whereas bioreactors provide
environmental control. Scaffolds and bioreactors also provide
a multitude of regulatory signals such as cytokines (diffusing
or immobilized) and physical factors (hydrodynamic shear,
mechanical stretch, and electrical gradients). Both in vivo
(during development and regeneration) and in vitro (for tis-
sue engineering), the cues presented to cells are the princi-
pal determinants of the phenotypic nature and function of
the resultant tissues. Hence, the design of tissue engineering
systems is necessarily inspired by biology (in either the de-
veloping or adult organism). The complementary engineering
principles help recapitulate the combinations of parameters
in the native environments of a specific tissue or organ, to
orchestrate the conversion of ‘‘collections of cells’’ into specific
tissue phenotypes.
Tissue engineering thus opens several exciting possibilities:
(i) to create functional grafts suitable for implantation and
repair of failing tissues, (ii) to study stem cell behavior and
developmental processes in the context of controllable 3D
models of engineered tissues, and (iii) to utilize engineered
tissues asmodels for studies of physiology and disease. Three-
dimensional environments that capture the molecular, struc-
tural, and physical factors regulating cellular processes and at
the same time provide control and monitoring of environ-
mental factors are instrumental toward these goals. More-
over, essentially the same biologically inspired blueprints
define the engineering design of each of these systems. We
discuss key components of tissue engineering systems—
biomaterial scaffolds and bioreactors—in light of the research
and utilization of stem cells for tissue engineering.
Biomaterials
An important component to the stem cell microenviron-
ment is the surrounding matrix, which includes numerous
chemical and biophysical cues. In a natural setting, this en-
vironment consists of the ECM, composed of collagens, other
proteins, polysaccharides, and water, whose structure is
dependent on the location and function of the tissue. For
instance, cartilage has a high proteoglycan content within a
strong collagen network, a matrix that gives this tissue its
important mechanical properties to sustain natural loading.
In contrast, tendon is highly anisotropic with respect to ECM
orientation, making mechanical properties directionally de-
pendent. Various proteins and peptides in the ECM control
cellular interactions and receptor binding. Also, factors such
as ECM mechanics and constriction of cell shape can play a
role in the differentiation of stem cells and can be engineered
into synthetic matrices for directed differentiation. Advances
in material synthesis and processing have opened up a range
of synthetic and natural materials for use in controlled mi-
croenvironments.
A wide variety of materials with a range of properties have
been designed and utilized for interactions with stem cells.10
Thesematerials have been fabricated into porous, fibrous, and
hydrogel scaffolds.11 Porous scaffolds provide macroscopic
voids for the migration and infiltration of cells, whereas
fibrous scaffolds may be fabricated on a size-scale that
mimics the native ECM and may be aligned to control cellu-
lar alignment.12 Alternatively, hydrogels are water-swollen
polymers that may be fabricated from natural ECM compo-
nents or synthetic materials and can be engineered to include
capabilities of native tissues (e.g., those present during early
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development). Figure 1 outlines a variety of parameters that
can be engineered in both 2D and 3D culture environments
that can influence stem cell behavior (e.g., self-renewal, mi-
gration, and differentiation). Also, representative images of
stem cell interactions on 2D surfaces, in fibrous scaffolds, and
within hydrogels are shown. The morphology of the cell is
distinct, based on the culture environment (i.e., spread in 2D
and rounded in 3D), as found in vivo. This section will review
several important advances in the design of biomaterials to
control stem cell behavior, specifically material chemistry and
physical properties.
Chemical cues to control stem cell behavior
Both natural and synthetic materials have been inves-
tigated for interactions with stem cells and to control their
behavior.13 The benefits to natural materials include their
ability to provide signaling to the encapsulated cells by
several different mechanisms: through surface receptor in-
teractions, by uptake in soluble form, and via degradation by
cell-instructive enzymes. The limitations to such materials
are that they may be difficult to process without disrupting a
potentially important hierarchical structure, and that gels
formed from natural materials generally have poor mechan-
ical properties and the potential for an immune response de-
pending on the source of the material. Alternatively, synthetic
biomaterials have wide diversity in properties that may
be obtained and tailored with respect to mechanics, chemis-
try, and degradation. Additionally, the processing of syn-
thetic materials into desired structures may be much simpler
than with natural materials. However, potential limitations to
the use of synthetic materials include toxicity and a limited
repertoire of cellular interactions, unless they are modified
with adhesion peptides or designed to release biological
molecules.
Examples of natural materials that have been used to cul-
ture stem cells include Matrigel, collagen, alginate, fibrin, and
hyaluronic acid (HA).10,13 Matrigel consists of a mixture of
molecules derived from natural ECM and has been investi-
gated extensively for the culture of cells and particularly stem
cells.14 The complexity and derivation from natural tissues
has motivated its use in cultures, particularly for embryonic
stem cells (ESCs), due to its mimicking of natural structures.15
Since collagen is abundant in native ECM and interacts with
FIG. 1. Manipulating the stem cell microenvironment in 2D and 3D. Schematic of controllable parameters (e.g., matrix
properties and culture environment) for altering stem cell microenvironmental behavior in both 2D and 3D. Human MSC
morphology (stained with Live=Dead) when seeded in 2D on a biodegradable elastomer (A), on the surface of an electrospun
fibrous scaffold from a biodegradable elastomer and gelatin (autofluoresces red) composite (B, inset is SEM of scaffold), and
when encapsulated in 3D in a photocrosslinked hyaluronic acid hydrogel (C). These are examples where the biomaterial
structure dictates the cellular morphology. Work by the Burdick laboratory and previously unpublished. Color images
available online at www.liebertonline.com=ten.
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cells via integrin binding, 3D collagen gels have been widely
used for stem cell encapsulation, including mesenchymal
stem cells (MSCs)16 and ESCs.17 Alginate is a seaweed-
derived polyanion that forms hydrogels through ionic cross-
linking. Although there are no direct cellular interactions,
alginate forms stable hydrogels that become soluble through
the dissociation of polymer chains. ESCs have been encap-
sulated and differentiated in alginate hydrogels for a variety
of applications both in vitro and in vivo.18,19 Additionally, fi-
brin has been used for the culture of murine ESCs.20
HA is a polysaccharide found in many tissues and has been
modified to form hydrogels with controlled properties that
allow for the encapsulation of viable cells.21,22 Cells may in-
teract with HA through receptor binding, primarily CD44,
and degrade HA with hyaluronidases. These HA hydrogels
have been investigated for the culture and growth of undif-
ferentiated human ESCs23, and an example of colonies of cells
in the HA hydrogel is shown in Figure 2A. The cells were
encapsulated using a photoinitiated polymerization, which is
a technique that has been widely used for encapsulating vi-
able cells in hydrogels.24 When necessary, entrapped cells can
be removed from the gel with the addition of exogenous hy-
aluronidases and then differentiated after formation of em-
bryoid bodies. Importantly, the colonies of ESCs remained
undifferentiated in the HA hydrogels, but spontaneously
differentiated in hydrogels formed from dextran, a polysac-
charide with a similar structure (as shown in Fig. 2B). This
example illustrates the importance of the biomaterial chem-
istry for controlling stem cell differentiation. Notably, the
simple addition of soluble factors to these culture environ-
ments induced differentiation by entrapped cells, without the
need to change the culture setting (e.g., from 2D culture on a
feeder layer into the 3D embryoid body culture).23
Synthetic materials investigated for stem cell cultures are
widespread.10,13 Both nondegradable and materials that de-
grade through either hydrolytic or enzymatic mechanisms
have been synthesized, and one advantage is the tunability
and versatility of these physical properties.24 Poly(a-hydroxy
esters) have been extensively used in the field of tissue en-
gineering, primarily due to their history of biocompatibility
and use in medicine. One composition was seeded with
human ESCs for the regeneration of numerous tissues, in-
cluding vascular and neural structures.25,26 Differentiation
was induced through incorporation of the appropriate
growth factors in culture media.
Poly(ethylene glycol) (PEG) hydrogels are one example of a
synthetic material that has been investigated for the encap-
sulation and culture of stem cells. PEG hydrogels are inher-
ently hydrophilic, so protein adsorption is minimal, which
allows these materials to prevent nonspecific material inter-
actions. Thus, PEG hydrogels are often modified with teth-
ered groups, such as adhesion peptides27,28 or phosphates29 to
alter cellular interactions. PEG hydrogels have been used for
the culture and differentiation of stem cells toward the engi-
neering of numerous tissues. Another hydrogel material for
stem cell encapsulation includes self-assembling peptide gels.
These gels form fibril nanometer–sized structures similar to
the native ECM through the assembly of engineered peptides
with the appropriate ionic and hydrophobic interactions.30
Self-assembling peptides have also been used for the con-
trolled differentiation of stem cells through careful selection of
the peptides. In one study, laminin-derived IKVAV peptide
sequences were utilized to form gels that selectively differ-
entiated neural progenitor cells into neurons.31
Hydrogels may also be synthetic, and still mimic many of
the cues found in natural matrices. For example, Hubbell and
coworkers fabricated hydrogels that incorporate adhesive
and enzymatically degradable cues to support cellular mi-
gration.32 Importantly, both types of cues are necessary for
cells to migrate in the hydrogels. Toward stem cell differen-
tiation, it is important to design environments that are per-
missive to important cellular behaviors, such as migration
and cell–cell interactions, depending on the differentiation
pathway (i.e., cell type and tissue) of interest. These types
of hydrogels have been used toward culture environments
for the self-renewal of ESCs. As one example, poly(N-
isopropylacrylamide-co-acrylic acid) (p(NIPAAm-co-AAc))–
based hydrogels crosslinked with peptides and incorporating
semi-interpenetrating networks of adhesive peptides have
been developed for the culture of ESCs in 2D.33
Mechanical and shape cues to control stem
cell differentiation
Biomaterials can be fabricated into structures that exhibit
a wide range of mechanical properties with moduli from the
FIG. 2. Matrix chemistry
controls stem cell differentia-
tion. Colonies of human ESCs
encapsulated in 3D hya-
luronic acid hydrogels and
stained for markers of un-
differentiation (green, Oct4;
red, SSEA4 (A) and compared
using light microscopy (left)
and histology (right) to hu-
man ESCs encapsulated in
dextran hydrogels (B).
Colonies of hESCs maintain
undifferentiated in HA
hydrogels and spontaneously differentiated in dextran hydrogels with a similar chemical structure, indicating the importance
of biomaterial chemistry on cellular interactions. Reprinted with permission from Gerecht et al.23 Copyright (2007) National
Academy of Sciences, USA. Color images available online at www.liebertonline.com=ten.
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Pa through the GPa range. Toward the differentiation of
adult MSCs, hydrogels have been engineered to exhibit a
wide range of mechanical properties that correlate to the
mechanical properties of native tissues.34 When MSCs were
seeded on the surface of these hydrogels (polyacrylamide
gels modified with collagen), they showed lineage specifica-
tion depending on the substrate mechanics. Importantly,
MSC differentiation correlated with the in vivo matrix elas-
ticity (i.e., soft substrates tend toward neural, intermediate
substrates tend toward muscle, and stiffer substrates tend
toward bone) in the absence of any known inducing soluble
factors.34 Representative staining of MSCs on the gel surfaces
with varied moduli is shown in Figure 3. Phenotype com-
mitment was modified with soluble factor inclusion over
the first week of culture; however, longer cultures prior to
soluble factor addition were defined by matrix elasticity. The
cues from matrix mechanics are thought to occur by the cell
‘‘pulling’’ on the matrix and then generating signals based on
this force. The inhibition of nonmuscle myosin II blocked the
ability of cells to differentiate based on matrix elasticity. Al-
though this work was performed in 2D, which may limit its
applicability in the fabrication of 3D tissue structures, it is
anticipated that the results will correlate to a more 3D tissue-
like environment where cells are surrounded on all sides by
the matrix.
Using soft lithography techniques, researchers have in-
vestigated the influence of spatially patterned adhesion mol-
ecules on cellular behavior, including differentiation.35 These
patterning tools have been used to investigate factors such as
cell spreading and shape on MSC differentiation, through
control over the cellular cytoskeleton. MSCs patterned on
larger islands of adhesion ligands, which allowed for cell
spreading tended to differentiate into osteoblasts, whereas
cells on smaller islands where cells stayed rounded differen-
tiated into adipocytes.35 Representative staining and quanti-
fication of differentiation in this system is shown in Figure 4.
This work indicated that stem cell lineage commitment was
regulated by RhoA and is a consideration in the design of
biomaterials for stem cell cultures.
Controlled delivery of soluble factors
Soluble factors such as growth factors and cytokines are
important for the initiation and control of stem cell differen-
tiation. Regulatory molecules can be added to the culture
media or secreted by the cells to induce differentiation, as, for
example, for human MSCs, which can be directed to form a
variety of cell lineages.36 In other cases, it is advantageous to
deliver the molecules directly from the material, particularly
for in vivo applications, or where spatial and temporal mole-
cule delivery is desired. The molecules to be delivered include
factors that can control differentiation, such as basic fibro-
blast growth factor, members of the transforming growth
factor–b family, small molecules such as retinoic acid or
FIG. 3. Matrix mechanics
directs stem cell differentia-
tion. Matrix mechanics–
dependent differentiation of
human MSCs stained for
b3-Tubulin, MyoD, and




bar¼ 5mm). MSC differentia-
tion correlates to tissue-
specific mechanical properties
(e.g., soft leads to neural dif-
ferentiation, whereas stiff
leads to osteogenic differenti-
ation). Reprinted with per-
mission from Engler et al.34
Color images available online
at www.liebertonline.com=ten.
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plasmid DNA that can induce growth factor production
by cells. Molecule release is typically controlled through dif-
fusion, degradation, or combinations of these two factors,
leading to a wide range of delivery profiles.37 Alternatively,
regulatory molecules can be immobilized on the surface of
biomaterials, which leads to enhanced spatial control, po-
tentially through gradients that can mediate cellular migra-
tion. One recent example involves the combined application
of scaffold-immobilized RGD and microencapsulated VEGF
to induce vascular differentiation of human ESCs.38 Although
it would be difficult to review the large amount of work that
has been completed in this general area, there are studies that
illustrate the importance of controlled molecule delivery. For
instance, multiple growth factors have been delivered from
the same scaffold sequentially based on polymer degradation
rates,39,40 which opens up the possibility of controlled tem-
poral delivery for complex signaling cascades in stem cells.
In several studies, biodegradable particles have been en-
capsulated with stem cells in hydrogel networks to provide
sustained delivery of factors to modulate stem cell differen-
tiation.41
Bioreactors
Bioreactors are generally defined as devices in which
biological processes (such as cell expansion, differentiation,
or tissue formation on 3D scaffolds) occur under tightly
controlled environmental conditions (such as exchange of
oxygen, nutrients, and metabolites, and application of mo-
lecular and physical regulatory factors).42 In comparison
with monolayer cultures, 3D systems have demanding mass-
transport requirements to achieve tissue uniformity and
avoid widespread necrosis in the inner regions of scaffolds.
Typically, internal mass transfer relies on a combination of
diffusion and convection and depends on cell density, scaf-
fold structure, and diffusional properties. The external mass
transfer is in turn a function of bioreactor hydrodynamics.
Design of a tissue engineering bioreactor should ideally
incorporate quantitative understanding of the native envi-
ronment and address the specific requirements for the tissue
of interest. Tissue-engineering bioreactors are designed to
precisely regulate the cellular microenvironment to support
cell viability and 3D organization and provide spatial and
temporal control of signaling. This overall requirement
translates into a set of practical design objectives: (i) rapid and
controllable expansion of cells; (ii) enhanced cell seeding of 3D
scaffolds (at a desired cell density, high yield, high kinetic
rate, and spatial uniformity); (iii) efficient local exchange
of oxygen, nutrients, and metabolites; and (iv) provision of
physiological stimuli.42 Current designs incorporate cascades
of biological and physical stimuli to exert greater influence
over cellular differentiation and development into functional
tissue constructs. Bioreactors are often custom designed to
account for specific mechanisms of nutrient transfer and
specific physical factors inherent in the native tissue.
Bioreactors are also utilized to optimize process vari-
ables prior to actual tissue engineering applications, to in-
vestigate the physiological ranges of parameters (e.g., oxygen
and shear) and their synergistic effects, in studies of disease
models and drug screening. These bioreactors are often de-
signed to be modular, mini-scaled, and multiparametric, to
economize cells and reagents, and to increase the number of
samples up to the high-throughput designs. In a general case,
these bioreactors are not cell- or tissue-specific and are suit-
able to test multiple combinations of parameters to optimize
conditions on small scales prior to use in tissue-engineering
bioreactors, which are much less practical for conducting
screening and optimization studies.
Perfusion for local control of cultured cells
and vascularized tissues
One of the critical factors of cell survival and function,
in vitro and in vivo, is the exchange of nutrients and waste
with every cell. For tissues that are normally vascularized
(e.g., muscle and bone), engineering of thick and compact
grafts consisting of viable and well-differentiated cells re-
quires some form of perfusion through the developing tissue.
Otherwise, diffusional gradients of oxygen reduce the for-
mation of viable tissue to an outer layer that is only about
100 mm thick (penetration depth of oxygen), and mostly ap-
optotic and dead cells in the bulk of the construct.43,44
In early studies of cardiac tissue engineering, a simple
bioreactor consisting of cartridges in which the cultured tis-
sue constructs were perfused with culture medium was de-
FIG. 4. Cell spreading controls stem cell lineage specifica-
tion. Human MSC adipogenic (A, Oil Red O stain) and os-
teogenic (B, Alkaline Phosphatase stain) differentiation in
response to cell spreading through size of adhesive islands.
Quantification indicates that adipogenic differentiation is
favored on smaller islands, whereas osteogenic is enhanced
on larger islands where more spreading is allowed (C).
Reprinted with permission from McBeath et al.35 Color
images available online at www.liebertonline.com=ten.
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veloped to study the effects of hydrodynamic shear and
oxygen level on the viability and function of cardiac cells.45
Subsequently, it was shown that rapid inoculation of cardiac
cells into the porous scaffolds, using a thermally polymer-
izing hydrogel, followed by the immediate establishment of
medium perfusion through the seeded scaffold substantially
improved the viability and function of neonatal heart cells,
but also exposed the cells to hydrodynamic shear (non-
physiologic).43,46–48 The advantages and limitations of this
simple system have driven further developments of perfu-
sion systems.
A biomimetic approach to supply oxygen to engineered
cardiac tissue was established to mimic as closely as practi-
cally possible the convective-diffusive oxygen transport in
native vascularized tissues.47,49 To mimic the capillary net-
work, cells were cultured on porous scaffolds with an array of
channels perfused with culture medium (to provide a sepa-
rate compartment for medium flow) and the medium was
supplemented with an oxygen carrier (to mimic the role of
hemoglobin). This approach tends to provide in vivo–like
mechanisms of oxygen supply to cultured cells and can
overcome both the inherent limitations of diffusional trans-
port in conventional culture systems and the adverse effects of
shear in perfused nonchanneled tissue constructs.
The oxygen supply requirements are even more critical for
cultures of stem cells, because of major effects of oxygen on
cell survival and differentiation. Two types of perfused bio-
reactor systems have been primarily used in cultures of stem
cells: bioreactors for cultivation of encapsulated or aggregated
cells and bioreactors for cultivation of cells on porous 3D
scaffolds. One example of the first class of bioreactors is a
simple stirred flask with continuous perfusion of culture
medium and monitoring of oxygen levels, which enhanced
the yield and viability of the derivation of cardiomyocytes
from ESCs encapsulated in agarose gel micro-drops.50,51 An-
other example is a similar system with medium recirculation
for the expansion of neural mouse stem cells, shown to out-
perform several nonperfused systems, including static cul-
ture, stirred flasks, and rotating bioreactors.52
One design of a closed bioreactor with continuous perfu-
sion of culture medium has been successfully used over long
periods to derive large numbers of bone marrow–derived
osteogenic cells for clinical therapies.53 Further studies are
required to better characterize the effect of shear on ESCs in
perfusion cultures. Microfluidic systems for cultivation of
ESCs over a logarithmic range of flow rateswill likely enhance
these studies, as they enable tight control of hydrodynamic
shear and the monitoring of cell responses by fluorescent
microscopy.54
Recently, the use of perfusion bioreactors, in which the
medium is pumped through the culture vessel containing
cell suspensions, has been reported for the expansion of
mouse ESC lines on Petri dishes with a gas-permeable base55
and for the expansion of human ESC lines on feeder layers.56
Perfusion systems yielded substantially higher cell numbers
than regular static culture. Perfusion of cultures with con-
comitant cell retention can provide homogeneity of nutrient
supplementations, waste removal, and the maintenance of
cell-secreted factors.57 For stem cells to become a viable cell
source for drug screening, robust and reproducible processes
are needed for obtaining large numbers of cells with main-
tained phenotype and differentiation capacity into a range of
cell types.58 Some of the bioreactors currently under research
are likely to serve as precursors for the development of the
new generation of technologies for stem cell expansion.
The second class of bioreactors was extensively used to
culture adult humanMSCs on porous biomaterial scaffolds, to
facilitate cell seeding,59–61 proliferation,7 and osteogenic dif-
ferentiation30,59,62–67 (please also refer to a recent review68 for
more information on bioreactor designs for stem cell expan-
sion and differentiation). Perfusing a cell suspension directly
through the pores of a 3D scaffold was shown to enhance
the yield and spatial uniformity of cell attachment, and to
improve subsequent bone formation, presumably due to the
convective transport of the culture medium throughout the
entire scaffold volume.60,69 An attractive feature of the perfu-
sion bioreactors is that the whole process occurs in one single
sequence (Fig. 5, left) and that the bioreactor can be closed,
which helps streamline the engineering process and reduce
the safety risks associated with the transferring of constructs
between bioreactors.70
Medium perfusion through constructs also enhanced bone
formation67,71–74 as a result of improved nutrient transfer
and the intrinsic shear stresses associated with the medium
flow. Shear forces—a physiologically relevant stimulus—
have been shown to specifically influence the expression of
osteogenic genes in osteoblasts,73 and to increase the depo-
sition of mineralized matrix71,73,75 by mechanisms associated
with these genes76 and further enhanced by dynamic flow.74
We recently developed a perfusion bioreactor that enables
the cultivation of up to six constructs simultaneously, with
medium perfusion and imaging compatibility77,78 (Fig. 5,
right).
Mechanical loading for conditioning of habitually
loaded tissues
Mechanical stimuli represent major regulators of the de-
velopment and function of many tissues, including mus-
culoskeletal (cartilage, bone, ligament, tendon, and skeletal
muscle) and cardiovascular (myocardium, heart valve, and
blood vessels) tissues. Mechanical forces regulate cell physi-
ology under normal and pathological conditions, and mod-
ulate ECM synthesis and organization at various hierarchical
levels—from molecules to whole tissues and organs. It is
generally accepted that the structure and function of tissues
and organs reflect the acting physical forces, with profound
interactive effects. From the early days of tissue engineering,
mechanical ‘‘conditioning’’ of cells cultured on biomaterial
scaffolds was explored based on the premise that the same
forces that govern tissue development and remodeling in vivo
would also enhance tissue development and function in vitro.
In several notable studies, stimulation protocols were de-
signed to provide deformational loading of cartilage, me-
chanical tension of ligaments and muscle, and flow-induced
stretch of blood vessels. The development of specialized bio-
reactors was a major contributing factor to these studies,
which initially focused on the assembly of differentiated an-
imal cells (e.g., bovine chondrocytes and rat cardiomyocytes)
and recently have shifted toward human MSCs and ESCs.
For functional tissue engineering, bioreactors are utilized to
recreate the physiologic loading environment and foster the
growth of tissue constructs with mechanical properties and
compositions enabling the immediate load-bearing function
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following implantation in vivo. For articular cartilage, defor-
mational loading and hydrostatic pressure are primary com-
ponents of the physical cell environment, and these forces
have thus been employed in tissue engineering of cartilage.
Most investigators utilized the regime of dynamic unconfined
compressive loading between two impermeable platens, in-
ducing the compressive and tensile strains with a minimal
change in tissue volume, and giving rise to fluid flow gradi-
ents that enhance mass transport.79 The original approach,
involving mechanical loading of agarose-encapsulated chon-
drocytes in conjunction with the supplementation of growth
factors to culture medium, has been extended to human
MSCs,80,81 human ESCs, other hydrogels,82 and the cultiva-
tion of osteochondral grafts79,83 (Fig. 6A).
As compared to chondrocytes, human MSCs accumulated
lower amounts of cartilaginous tissue matrix and developed
lower mechanical properties over the same time periods.80
The finding that these differences are not a result of delayed
differentiation suggests that the translation of these protocols
from differentiated animal to undifferentiated human cells
will necessitate the modifications of loading regimes or
growth factor supplementation, or both. Studies by other
groups indirectly support this expectation, by showing that
mechanical stimulation and growth factors, applied sepa-
rately or in combination, differentially regulated the expres-
sion of cartilage-specific genes in human MSCs derived from
bone marrow aspirates of embryoid bodies.82,83
The same paradigm of functional tissue engineering was
also applied to the in vitro creation of tendons by bioreactor
cultivation of human MSCs on collagen-based scaffolds, with
mechanical stimulation.84–86 In two related early studies, hu-
man ligaments were engineered by applying a combination of
dynamic tension and torsion designed to mimic forces in the
knee. Interestingly, mechanical loading alone, without the ap-
plication of specific growth factors, induced the alignment of
human MSCs and the accumulation of ligament-specific
markers, in favor of alternate differentiation paths into cartilage
or bone.85 In studies conducted by Butler et al., the function of
FIG. 5. Perfusion bioreactors for enhanced mass transport. Left: example of an integrated perfusion bioreactor system for cell
seeding and prolonged culture of tissue constructs within a single device. (A) Cell seeding pathway: alternating bi-directional
flow of cell suspension, without cell recirculation through the pump. (B) Cultivation pathway: transfer from seeding to
cultivation is made by simply diverting the medium flow to a separate perfusion loop for prolonged culture. (C) Scaffold
chamber: the scaffold is inserted into a removable holder and held in place by its outer 1mm periphery. A straight region helps
to fully develop the flow before reaching the construct. Right: Simple bioreactor system for tissue engineering of bone and
osteochondral grafts that enables cultivation of up to six tissue constructs simultaneously, with direct perfusion and imaging
capability. (D) Schematic presentation of the bioreactor system. The flow channels in the bioreactor provide an even distri-
bution of medium flow between the six constructs (4–10mm in diameter, up to 7mm high) that are press-fit into the culture
wells.77 (E) An example of a cartilage-bone plug from a gel layer overlaying the porous scaffold; both phases are seeded with
humanMSCs, and the construct is cultured in the perfusion bioreactor (D). (F) Example of an anatomically correct construct of a
human temporomandibular joint condyle that was cultured in a bioreactor (D). Images (A)–(C) are reproducedwith permission
from Wendt et al.69 Color images available online at www.liebertonline.com=ten.
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engineered ligaments was substantially improved by using
composite collagen scaffolds, mechanical stimulation in biore-
actors, and precise measurements of forces acting in vivo.84
Native vessels develop and function in a complex me-
chanical environment that involves at least four different
flow-induced factors: (i) hydrodynamic shear acting on
endothelial cells (ECs)due tobloodflowandonsmoothmuscle
cells (SMCs) due to interstitial flow, (ii) luminal pressure, (iii)
circumferential mechanical stretch, and (iv) longitudinal
stretch. With a premise that the function of native vessels
depends on the alignment and orientation of cells and ECM,
which in turn can be mediated by mechanical forces, various
bioreactors have been established to expose engineered blood
vessels to mechanical stimulation. One of the designs involves
the use of a mandrel to induce circumferential stretch and
alignment of the cells encapsulated in the hydrogel.87 In
separate studies that used a simple systemwith humanMSCs
grown on a silicone tube, combined application of the shear
flow, radial stretch, and pulsatile pressure was shown to in-
duce the expression of EC and SMC markers in cultured
MSCs.88
Another meritorious design is a biomimetic perfusion
system for engineering small-diameter blood vessel grafts.
The system was first applied to ECs and SMCs from various
species, and then the human bone marrow–derived MSCs
were used as a source of SMCs.89,90 The approach involved
seeding of SMCs (or their MSC-derived precursors) into tu-
bular fibrous scaffolds and cultivation under pulsatile flow
conditions using a perfusion bioreactor (Fig. 6B). Over 8weeks
of culture, vessels engineered using young bovine cells de-
veloped rupture strengths greater than 2000mmHg, had su-
ture retention strengths of up to 90 g, and had collagen
contents of about 50% of normal.91 When vessel walls were
engineered using human MSCs, the cyclic strain resulting
from pulsatile flow inhibited cell proliferation independent of
cell culture substrate, whereas its effects on MSC differentia-
tion into SMCs depended on the presence of ECM and me-
dium supplements.
Similar to blood vessels, native and tissue-engineered heart
valves have been observed to respond to a combination of
mechanical stimuli, including cyclic flexure, cyclic stretch, and
hydrodynamic shear. The application of flexure and flow
dramatically accelerated tissue formation in the bioreactor,
resulting in significantly increased collagen contents and tis-
sue stiffness.91 A novel bioreactor was developed in which
these mechanical stimuli can be applied to an engineered
heart valve independently or in combination.92 The bioreactor
consists of two identical chambers, each holding up to 12
rectangular tissue specimens subjected to cyclic flexure,
stretch, and steady laminar flow. This design provides a tool
for the study of mechanical stimuli on the in vitro engineered
heart valve tissue formation.
FIG. 6. Mechanical stimulation bioreactors for functional tissue engineering. (A)
Bioreactor system for dynamic deformational loading of engineered cartilage. Con-
structs are placed in the base of a standard Petri dish modified with a custom agarose
template to maintain positioning during loading, which is carried out by applying
sinusoidal deformation. Reproduced with permission fromHung et al.79 (B) Bioreactor
system with pulsatile flow for engineering blood vessels. Fibrous tubular scaffolds
seeded with aortic smooth muscle cells were placed over silicone tubing and subjected
to pulsatile flow inducing 5% radial strain. After 8 weeks of culture, the silicone tubing
was removed and a confluent layer of endothelial cells was formed in vessel lumens.
Reproduced with permission from Niklason et al.89 (C) Bioreactor with mechanical
stimulation for cardiac tissue engineering. Top left: Casting mold. Top right: Cells
seeded into a collagen gel and cultured without stimulation for 1–4 days. Bottom left:
Stretch apparatus for the application of unidirectional and cyclic stretch (10%, 2Hz).
Bottom right: Multiple rings connected into a construct for implantation studies. Re-
produced with permission from Zimmermann et al.95 Color images available online at
www.liebertonline.com=ten.
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Application of cyclic mechanical stretch to neonatal rat
heart cells in collagen–Matrigel gels, introduced by the Es-
chenhagen group, represents a significant approach to tissue
engineering of well-differentiated cardiac tissue grafts with
the development of contractile forces.93 This approach is also
‘‘biomimetic’’ in nature, as it involves the utilization of me-
chanical stretch as a physiologically relevant signal for cell
differentiation (Fig. 6C). These constructs were suitable for
implantation on infarcted rat hearts, and they delayed the
thinning of the heart wall and induced functional improve-
ment.93 However, heart cells are postmitotic and cannot be
used as a source for human applications. This motivated the
considerations of the applicability of the same approach to
human ESCs.94 Two challenges that have been identified are
the need to derive multiple cell lineages that constitute the
heart tissue (cardiac myocytes, endothelial cells, smooth
muscle cells, and fibroblasts) from ESCs, and to generate cell
numbers that are high enough for growing clinically sized
implants. The need to vascularize these tissues is also clearly
recognized.
Microdevices for stem cell analysis
Microscale technologies are potentially powerful tools for
addressing some of the challenges in tissue engineering.96
Micro-Electro-Mechanical Systems (MEMS) can be used to
control features at length scales from 1 mm to 1 cm97 and are
compatible with cells to control the cellular microenviron-
ment in culture and miniaturize assays for high-throughput
applications. Specifically, microfabrication with techniques
such as soft lithography can be used to fabricate microscale
devices without the use of expensive ‘‘clean rooms’’ and
photolithographic equipment.97,98 Resolutions as low as sev-
eral hundred nanometers may be achieved and used to
control the topography and spatial distribution of molecules
on a surface, as well as the subsequent deposition of cells.99
Soft lithographic methods can also be used to fabricate mi-
crofluidic channels and scaffolds for tissue engineering in a
convenient, rapid, and inexpensive manner.100 The emer-
gence of these tools is allowing for precise microenviron-
mental control of stem cells.
Microfluidic systems allow for controlled soluble and che-
mical environments (both 2D and 3D) for stem cells to probe
these interactions to better understand differentiation and
tools to manipulate and control their behavior. Chung et al.101
used controlled gradients of growth factors to spatially con-
trol the proliferation and differentiation of neural stem cells
using MEMS devices. More complex microbioreactors have
also been developed to screen soluble factor and biomate-
rial synergistic effects on stem cells in both 2D (attached to
substrates) and 3D (encapsulated in hydrogels)102 (Fig. 7).
Using automated image analysis, hESCs in these environ-
ments were assessed with respect to the expression of nuclear
and cytoplasmic markers. Similarly, microdevices with mi-
crocontainers that immobilize colonies of cells have been used
with rapid output analysis and illustrated good cultivation
when perfused.103 The device was designed so that individual
wells could be electrically stimulated to excite cells. Also,
devices have been constructed that allow for the culture of
cells under differential flow rates to control the soluble mi-
croenvironment and showed little proliferation of ESCs under
static culture and enhanced proliferation under flow.54
Microengineering approaches can also be used to minia-
turize cell–material interaction experiments and perform
them in a highly parallel manner. This may be important in
the identification of soluble factors, biomaterials, or synergy
between these parameters. For example, arrays can be used
to localize and track individual cells, enabling clonal analysis
of stem cell fates.104 Also, clonal populations of neural stem
cells were immobilized within microfabricated structures,
and their progeny was tracked using real-time microscopy,
yielding information about cellular kinetics and cell fate
decisions in a high-throughput manner.105
Using this approach, it is possible to study the response of
individual stem cells to various microenvironmental signals.
Recently, robotic spotters capable of dispensing and im-
mobilizing nanoliters of material have been used to fabricate
microarrays, where cell–matrix interactions can be tested and
optimized in a high-throughput manner. In these studies,
synthetic biomaterial arrays have been used to test the in-
teraction of stem cells with various extracellular signals.106
By using microarrayers, thousands of polymeric materials
were synthesized and their effects on the differentiation of
human ES cells106 and MSCs107 were evaluated. These in-
teractions have led to unexpected and novel cell–material
interactions. In another example, combinatorial matrices of
various natural ECM were tested for their ability to maintain
the function of differentiated hepatocytes and to induce he-
patic differentiation from murine ES cells.108 Although these
approaches were not performed in 3D settings or with in-
teracting cell populations, they are indicative of the potential
of these techniques for understanding and studying the cel-
lular microenvironments. Finally, Demirci and Montesano109
immobilized cells in biological fluids and hydrogels using
acoustic droplets to potentially investigate stem cell differ-
entiation at the single-cell level.
Conclusions and Future Perspectives
Tissue engineering and regenerative medicine are increas-
ingly relying on advanced scaffolds and bioreactors that
provide control over multiple molecular and physical regu-
latory signals within sophisticated 3D culture environments.
There are some general requirements applicable to any cell
type or application (such as biocompatibility and degradation
for a scaffold, and the control of medium composition, oxy-
gen, and pH for a bioreactor). There are also requirements that
are cell or tissue specific (such as specific structure and me-
chanical properties of the scaffold, cascades of signals, and
need for physical stimulation of the cells). Distinctly different
scaffold and bioreactor designs are now being utilized to en-
gineer distinctly different tissues, or to study and characterize
cells. In general, the utilization of 3D biomaterial scaffolds and
bioreactors instead of ‘‘flat biology’’ or simple Petri dishes
enables more rigorous experimentation under conditions that
are tightly controlled and closer to those present in vivo.
The future needs outlined in the first review of the field
of tissue engineering110 included (i) learning what controls
cell differentiation, (ii) better techniques for cell sourcing
and preservation, (iii) advanced scaffolds that combine ad-
vantages of native and synthetic materials and incorporate
controlled-release techniques, (iv) vascularization, and (v) in
vitro systems that can predict in vivo cellular events. Today,
major advances have been made in all of these areas, but
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FIG. 7. Microarray bioreactors for in vitro studies. (A) The micro-bioreactor wells (3.5mm in diameter) are arranged in an
array. Each of three inlets delivers medium (red) through the flow transducers to four wells (orange) via microfluidic
channels (100mm wide); waste medium exits each bioreactor via a separate set of channels (yellow). (B) Two configurations
were used: a bottom inlet=outlet (BIO) configuration, and a middle inlet=outlet (MIO) configuration (right) that allows for 3D
cultivation. (C) Image of a single MBA with compression frame and fluidic connections. (D) Experimental setup. MBAs and
medium collectors are placed in an incubator, and the medium reservoirs are maintained external to the incubator in an ice
bath. (E) Schematic presentation of the human ESC culture in the microarray bioreactor system. Images (A)–(D) are from
Figallo et al.102 and reproduced by permission of The Royal Society of Chemistry. Color images available online at www
.liebertonline.com=ten.
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muchmore needs to be learned and completed before the next
generation of biologically inspired technologies are possible
that are sophisticated enough to elicit in vivo–like cell re-
sponses yet simple and practical enough for use in biology
and medicine. In particular, further progress is needed in the
identification of biological ‘‘blueprints’’ of engineering sys-
tems, and in the development of technologies for microenvi-
ronmental control, and these two areas are likely to progress
in parallel and increasingly interact in the future.
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